Fsd Pharma Class Stock Price History
| HUGE Stock | USD 0.60 0.02 3.23% |
Below is the normalized historical share price chart for FSD Pharma Class extending back to June 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FSD Pharma stands at 0.60, as last reported on the 16th of April 2024, with the highest price reaching 0.62 and the lowest price hitting 0.60 during the day.
If you're considering investing in FSD Stock, it is important to understand the factors that can impact its price. FSD Pharma Class secures Sharpe Ratio (or Efficiency) of -0.13, which denotes the company had a -0.13% return per unit of return volatility over the last 3 months. FSD Pharma Class exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm FSD Pharma's standard deviation of 3.89, and Mean Deviation of 2.71 to check the risk estimate we provide.
At present, FSD Pharma's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 41.6 M, whereas Sale Purchase Of Stock is projected to grow to (2.9 M). . At present, FSD Pharma's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 2.90, whereas Price Earnings Ratio is forecasted to decline to (2.06). FSD Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of June 2018 | 200 Day MA 1.043 | 50 Day MA 0.7829 | Beta 0.914 |
FSD |
Sharpe Ratio = -0.1347
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HUGE |
Estimated Market Risk
| 3.9 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average FSD Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FSD Pharma by adding FSD Pharma to a well-diversified portfolio.
Price Book 1.8219 | Enterprise Value Ebitda (1.34) | Price Sales 105.0253 | Shares Float 34.3 M | Wall Street Target Price 6 |
FSD Pharma Stock Price History Chart
There are several ways to analyze FSD Stock price data. The simplest method is using a basic FSD candlestick price chart, which shows FSD Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 21, 2024 | 1.06 |
| Lowest Price | April 12, 2024 | 0.6 |
FSD Pharma April 16, 2024 Stock Price Synopsis
Various analyses of FSD Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell FSD Stock. It can be used to describe the percentage change in the price of FSD Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of FSD Stock.| FSD Pharma Price Daily Balance Of Power | (1.00) | |
| FSD Pharma Price Rate Of Daily Change | 0.97 | |
| FSD Pharma Price Action Indicator | (0.02) |
FSD Pharma April 16, 2024 Stock Price Analysis
FSD Stock Price History Data
The price series of FSD Pharma for the period between Wed, Jan 17, 2024 and Tue, Apr 16, 2024 has a statistical range of 0.46 with a coefficient of variation of 13.4. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.81. The median price for the last 90 days is 0.83. The company completed 1:201 stock split on 16th of October 2019. FSD Pharma Class completed dividends distribution on 2019-10-16.| Open | High | Low | Close | Volume | ||
04/16/2024 | 0.61 | 0.62 | 0.60 | 0.60 | ||
| 04/12/2024 | 0.61 | 0.62 | 0.60 | 0.60 | 29,168 | |
| 04/11/2024 | 0.61 | 0.62 | 0.61 | 0.62 | 35,275 | |
| 04/10/2024 | 0.60 | 0.62 | 0.56 | 0.61 | 252,355 | |
| 04/09/2024 | 0.61 | 0.63 | 0.60 | 0.61 | 92,754 | |
| 04/08/2024 | 0.62 | 0.65 | 0.61 | 0.62 | 98,136 | |
| 04/05/2024 | 0.63 | 0.64 | 0.62 | 0.63 | 99,251 | |
| 04/04/2024 | 0.67 | 0.68 | 0.64 | 0.65 | 85,000 | |
| 04/03/2024 | 0.65 | 0.69 | 0.65 | 0.66 | 111,085 | |
| 04/02/2024 | 0.67 | 0.72 | 0.67 | 0.67 | 34,946 | |
| 04/01/2024 | 0.72 | 0.72 | 0.69 | 0.69 | 40,037 | |
| 03/28/2024 | 0.71 | 0.72 | 0.69 | 0.72 | 32,990 | |
| 03/27/2024 | 0.68 | 0.72 | 0.68 | 0.71 | 167,651 | |
| 03/26/2024 | 0.65 | 0.71 | 0.65 | 0.70 | 86,772 | |
| 03/25/2024 | 0.66 | 0.68 | 0.65 | 0.67 | 192,208 | |
| 03/22/2024 | 0.71 | 0.72 | 0.67 | 0.68 | 733,743 | |
| 03/21/2024 | 0.71 | 0.72 | 0.70 | 0.71 | 123,091 | |
| 03/20/2024 | 0.73 | 0.73 | 0.71 | 0.72 | 53,494 | |
| 03/19/2024 | 0.73 | 0.75 | 0.72 | 0.73 | 30,489 | |
| 03/18/2024 | 0.72 | 0.74 | 0.71 | 0.74 | 260,653 | |
| 03/15/2024 | 0.73 | 0.73 | 0.71 | 0.71 | 116,191 | |
| 03/14/2024 | 0.75 | 0.77 | 0.70 | 0.73 | 265,442 | |
| 03/13/2024 | 0.77 | 0.78 | 0.72 | 0.76 | 209,014 | |
| 03/12/2024 | 0.80 | 0.80 | 0.74 | 0.76 | 192,445 | |
| 03/11/2024 | 0.82 | 0.83 | 0.78 | 0.78 | 115,182 | |
| 03/08/2024 | 0.83 | 0.86 | 0.80 | 0.81 | 64,310 | |
| 03/07/2024 | 0.85 | 0.86 | 0.81 | 0.86 | 296,197 | |
| 03/06/2024 | 0.82 | 0.86 | 0.77 | 0.85 | 197,522 | |
| 03/05/2024 | 0.74 | 0.85 | 0.72 | 0.82 | 1,986,323 | |
| 03/04/2024 | 0.88 | 0.90 | 0.85 | 0.85 | 73,525 | |
| 03/01/2024 | 0.87 | 0.92 | 0.87 | 0.90 | 61,151 | |
| 02/29/2024 | 0.88 | 0.92 | 0.87 | 0.87 | 49,257 | |
| 02/28/2024 | 0.94 | 0.99 | 0.88 | 0.90 | 111,495 | |
| 02/27/2024 | 1.00 | 1.03 | 0.94 | 0.94 | 200,652 | |
| 02/26/2024 | 1.05 | 1.08 | 0.96 | 0.96 | 280,008 | |
| 02/23/2024 | 0.96 | 0.99 | 0.91 | 0.96 | 37,636 | |
| 02/22/2024 | 1.05 | 1.05 | 0.94 | 0.97 | 112,222 | |
| 02/21/2024 | 0.89 | 1.09 | 0.89 | 1.06 | 174,283 | |
| 02/20/2024 | 0.82 | 0.92 | 0.82 | 0.90 | 196,879 | |
| 02/16/2024 | 0.84 | 0.86 | 0.83 | 0.84 | 25,592 | |
| 02/15/2024 | 0.83 | 0.86 | 0.83 | 0.85 | 25,130 | |
| 02/14/2024 | 0.83 | 0.86 | 0.83 | 0.85 | 45,282 | |
| 02/13/2024 | 0.83 | 0.88 | 0.83 | 0.83 | 19,650 | |
| 02/12/2024 | 0.83 | 0.88 | 0.83 | 0.87 | 23,842 | |
| 02/09/2024 | 0.83 | 0.86 | 0.83 | 0.86 | 15,972 | |
| 02/08/2024 | 0.83 | 0.84 | 0.83 | 0.83 | 75,891 | |
| 02/07/2024 | 0.84 | 0.87 | 0.82 | 0.84 | 34,321 | |
| 02/06/2024 | 0.82 | 0.89 | 0.82 | 0.83 | 57,589 | |
| 02/05/2024 | 0.81 | 0.84 | 0.81 | 0.81 | 20,267 | |
| 02/02/2024 | 0.82 | 0.83 | 0.81 | 0.81 | 37,700 | |
| 02/01/2024 | 0.86 | 0.86 | 0.83 | 0.83 | 24,036 | |
| 01/31/2024 | 0.83 | 0.86 | 0.83 | 0.84 | 34,562 | |
| 01/30/2024 | 0.83 | 0.88 | 0.83 | 0.85 | 47,554 | |
| 01/29/2024 | 0.83 | 0.88 | 0.83 | 0.85 | 21,464 | |
| 01/26/2024 | 0.82 | 0.86 | 0.82 | 0.85 | 12,053 | |
| 01/25/2024 | 0.82 | 0.84 | 0.82 | 0.82 | 34,021 | |
| 01/24/2024 | 0.84 | 0.87 | 0.82 | 0.82 | 34,440 | |
| 01/23/2024 | 0.82 | 0.87 | 0.82 | 0.87 | 27,246 | |
| 01/22/2024 | 0.87 | 0.88 | 0.81 | 0.82 | 116,181 | |
| 01/19/2024 | 0.86 | 0.89 | 0.86 | 0.88 | 11,368 | |
| 01/18/2024 | 0.88 | 0.89 | 0.83 | 0.86 | 135,332 |
About FSD Pharma Stock history
FSD Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FSD is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FSD Pharma Class will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FSD Pharma stock prices may prove useful in developing a viable investing in FSD Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 39.6 M | 41.6 M | |
| Net Loss | -31.8 M | -30.2 M |
FSD Pharma Quarterly Net Working Capital |
|
FSD Pharma Stock Technical Analysis
FSD Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
FSD Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for FSD Pharma's price direction in advance. Along with the technical and fundamental analysis of FSD Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FSD to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.82) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in FSD Pharma Class. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.